IPCA Laboratories

BSE : 524494 | NSE : IPCALAB
Industry : Pharmaceuticals | ISIN : INE571A01038 | FreeFloat : 51.43% | FnO : Yes | LotSize : 650
Intellectual Capital (IC)5,245.29
Net Worth (NW)5,974.02
Intrinsic Worth (IW)11,219.31
Market Cap (MC)21,389.80
Economic Value Added-58.31
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)46.75%
IC Gross Margin (EBITDA/IC)23.48%
IC Net Margin (NPT/IC)13.91%
Knowledge Turnover (Sales/IC)1.12
Market to Intrinsic Value (MC/IW)1.91
As OfIntrinsic ValueMarket Price
31 Dec 2022Rs. 442.22Rs. 843.10
20 Mar 2023 ---- Rs. 781.25
-1.65     -0.21%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 789.14SellStrong Sell
KB > 50% : No50 DMA : Rs. 836.88
0 < M2IV < 1 : NoVol-Price trend : Falling
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-20
C
1073.76
1087.49
179.86
115.92
112.25
83.05
84.14
Jun-20
C
1534.40
1546.49
599.34
548.31
545.57
445.68
443.61
Sep-20
C
1361.10
1378.55
373.72
321.60
319.29
266.70
266.56
Dec-20
C
1409.83
1425.21
380.10
326.58
324.29
267.56
269.07
Mar-21
C
1114.66
1134.58
246.33
193.83
192.13
161.20
161.59
Jun-21
C
1565.79
1586.81
435.13
379.26
377.44
306.67
310.03
Sep-21
C
1544.43
1562.51
383.66
326.70
325.64
250.23
247.86
Dec-21
C
1430.47
1443.40
320.74
262.09
260.66
196.96
197.60
Mar-22
C
1289.10
1303.64
225.06
164.12
160.74
130.23
130.47
Jun-22
C
1585.74
1607.85
288.15
226.44
219.50
143.06
144.28
Sep-22
C
1600.95
1637.18
295.94
232.20
222.89
143.90
143.16
Dec-22
C
1546.00
1576.89
240.86
174.29
163.45
107.84
114.92
* C - Consolidated, S - Standalone